Suppr超能文献

先前被诊断患有乳腺癌是 BRCA1 和 BRCA2 携带者患乳腺癌的一个风险因素。

A prior diagnosis of breast cancer is a risk factor for breast cancer in BRCA1 and BRCA2 carriers.

机构信息

Women's College Research Institute, University of Toronto, Toronto, ON.

Beth Israel Deaconness Hospital, Boston, MA, U.S.A.

出版信息

Curr Oncol. 2014 Apr;21(2):64-8. doi: 10.3747/co.21.1656.

Abstract

BACKGROUND

The risk of breast cancer in carriers of BRCA1 and BRCA2 mutations is influenced by factors other than the genetic mutation itself. Modifying factors include a woman's reproductive history and family history of cancer. Risk factors are more likely to be present in women with breast cancer than in women without breast cancer, and therefore the risk of cancer in the two breasts should not be independent. It is not clear to what extent modifying factors influence the risk of a first primary or a contralateral breast cancer in BRCA carriers.

METHODS

We conducted a matched case-control study of breast cancer among 3920 BRCA1 or BRCA2 mutation carriers. We asked whether a past history of breast cancer in the contralateral breast was a risk factor for breast cancer.

RESULTS

After adjustment for age, country of residence, and cancer treatment, a previous cancer of the right breast was found to be a significant risk factor for cancer of the left breast among BRCA1 or BRCA2 carriers (relative risk: 2.1; 95% confidence interval: 1.4 to 3.0; p < 0.0001).

CONCLUSIONS

In a woman with a BRCA1 or BRCA2 mutation who is diagnosed with breast cancer, the risk of cancer in the contralateral breast depends on the first diagnosis. That observation supports the hypothesis that there are important genetic or non-genetic modifiers of cancer risk in BRCA carriers. Discovering risk modifiers might lead to greater personalization of risk assessment and management recommendations for BRCA-positive patients.

摘要

背景

BRCA1 和 BRCA2 基因突变携带者的乳腺癌风险受到基因突变本身以外的因素的影响。这些修饰因素包括女性的生殖史和癌症家族史。与没有乳腺癌的女性相比,患有乳腺癌的女性更有可能存在这些危险因素,因此双侧乳腺癌的风险不应是独立的。目前尚不清楚修饰因素在多大程度上影响 BRCA 携带者中首次原发性乳腺癌或对侧乳腺癌的风险。

方法

我们对 3920 名 BRCA1 或 BRCA2 基因突变携带者的乳腺癌进行了匹配病例对照研究。我们询问了对侧乳房是否有既往乳腺癌史是否是乳腺癌的危险因素。

结果

在调整年龄、居住国和癌症治疗后,发现右乳腺癌史是 BRCA1 或 BRCA2 携带者中左乳腺癌的显著危险因素(相对风险:2.1;95%置信区间:1.4 至 3.0;p<0.0001)。

结论

在诊断为乳腺癌的 BRCA1 或 BRCA2 基因突变女性中,对侧乳房的癌症风险取决于首次诊断。这一观察结果支持了这样一种假设,即在 BRCA 携带者中存在重要的遗传或非遗传癌症风险修饰因子。发现风险修饰因子可能会导致对 BRCA 阳性患者的风险评估和管理建议更加个性化。

相似文献

2
BRCA1/BRCA2 mutations in Japanese women with ductal carcinoma in situ.
Mol Genet Genomic Med. 2019 Mar;7(3):e493. doi: 10.1002/mgg3.493. Epub 2019 Jan 16.
4
Contralateral breast cancer after radiotherapy among BRCA1 and BRCA2 mutation carriers: a WECARE study report.
Eur J Cancer. 2013 Sep;49(14):2979-85. doi: 10.1016/j.ejca.2013.04.028. Epub 2013 May 21.
5
7
Effect of pregnancy as a risk factor for breast cancer in BRCA1/BRCA2 mutation carriers.
Int J Cancer. 2005 Dec 20;117(6):988-91. doi: 10.1002/ijc.21273.
8
10
Contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers.
J Clin Oncol. 2009 Dec 10;27(35):5887-92. doi: 10.1200/JCO.2008.19.9430. Epub 2009 Oct 26.

引用本文的文献

2
Glucose-dependent effect of insulin receptor isoforms on tamoxifen antitumor activity in estrogen receptor-positive breast cancer cells.
Front Endocrinol (Lausanne). 2023 Jun 9;14:1081831. doi: 10.3389/fendo.2023.1081831. eCollection 2023.
3
The risk of contralateral breast cancer: a SEER-based analysis.
Br J Cancer. 2021 Aug;125(4):601-610. doi: 10.1038/s41416-021-01417-7. Epub 2021 May 26.
4
Epidemiological characteristics of and risk factors for breast cancer in the world.
Breast Cancer (Dove Med Press). 2019 Apr 10;11:151-164. doi: 10.2147/BCTT.S176070. eCollection 2019.
5
Bilateral breast cancers.
Nat Rev Clin Oncol. 2014 Mar;11(3):157-66. doi: 10.1038/nrclinonc.2014.3. Epub 2014 Feb 4.

本文引用的文献

2
Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACE.
J Natl Cancer Inst. 2013 Jun 5;105(11):812-22. doi: 10.1093/jnci/djt095. Epub 2013 Apr 29.
3
The risk of breast cancer in women with a BRCA1 mutation from North America and Poland.
Int J Cancer. 2012 Jul 1;131(1):229-34. doi: 10.1002/ijc.26369. Epub 2011 Sep 22.
4
Family history of cancer and cancer risks in women with BRCA1 or BRCA2 mutations.
J Natl Cancer Inst. 2010 Dec 15;102(24):1874-8. doi: 10.1093/jnci/djq443. Epub 2010 Nov 23.
5
Incidence and prognosis of synchronous and metachronous bilateral breast cancer.
J Clin Oncol. 2007 Sep 20;25(27):4210-6. doi: 10.1200/JCO.2006.10.5056.
7
Age at menarche and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers.
Cancer Causes Control. 2005 Aug;16(6):667-74. doi: 10.1007/s10552-005-1724-1.
8
A comparison of bilateral breast cancers in BRCA carriers.
Cancer Epidemiol Biomarkers Prev. 2005 Jun;14(6):1534-8. doi: 10.1158/1055-9965.EPI-05-0070.
9
Breast-feeding and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers.
J Natl Cancer Inst. 2004 Jul 21;96(14):1094-8. doi: 10.1093/jnci/djh211.
10
Contralateral breast cancer in BRCA1 and BRCA2 mutation carriers.
J Clin Oncol. 2004 Jun 15;22(12):2328-35. doi: 10.1200/JCO.2004.04.033.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验